Literature DB >> 15244400

Deciding on transplantation for myelofibrosis: setting the record straight.

Ayalew Tefferi, H Joachim Deeg.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15244400     DOI： 10.4065/79.7.953

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  3 in total

1.  Objective, planimetry-based assessment of megakaryocyte histological pictures in Philadelphia-chromosome-negative chronic myeloproliferative disorders: a perspective for a valuable adjunct diagnostic tool.

Authors:  Zbigniew Rudzki; Rafał Kawa; Krzysztof Okoñ; Ewa Szczygieł; Jerzy Stachura
Journal:  Virchows Arch       Date:  2005-10-12       Impact factor: 4.064

Review 2.  Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia.

Authors:  William J Hogan; Mark R Litzow; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 3.952

3.  The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more "erythremic" and less "thrombocythemic": a molecular, histologic, and clinical study.

Authors:  Zbigniew Rudzki; Tomasz Sacha; Anastazja Stój; Sylwia Czekalska; Małgorzata Wójcik; Aleksander B Skotnicki; Barbara Grabowska; Andrzej Zduńczyk; Krzysztof Okoń; Jerzy Stachura
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.